The presence of tumor-infiltrating lymphocytes ahead of treatment may help predict response to platinum-based chemotherapy in women with triple-negative breast cancer, according to a new study.
The American Society of Clinical Oncology (ASCO) is updating its guidelines on adjuvant endocrine therapy to recommend tamoxifen for up to 10 years for women with nonmetastatic hormone receptor-positive breast cancer.
The 2014 ASCO Annual Meeting tweeters share their opinions on oncology care, and more. Here is a selection of their thoughts as expressed via social media.
New study challenges belief that inappropriate cancer treatments fuel health care costs, researcher says.
Implementation of the U.S. Preventive Services Task Force recommendations for low-dose computed tomography (LDCT) lung cancer screening is expected to increase lung cancer diagnoses and increase Medicare expenditure.
The American Society for Clinical Oncology (ASCO) has issued recommendations for the treatment of HER2-positive advanced breast cancer and advanced HER2-positive breast cancer with brain metastases.
The American Society of Clinical Oncology (ASCO) has updated its 2005 guideline for use of sentinel node biopsy in early breast cancer.
Millions lack access to quality cancer care; one-quarter of uninsured forgo care because of costs.
Results from PROCEDE 500, a clinical utility study with the Prolaris test, demonstrated the significant clinical value of Prolaris to physicians who are treating men with prostate cancer.
Combination vaccine significantly improves overall survival in pancreatic cancer, compared with single-component vaccine.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|